News
-
-
-
PRESS RELEASE
Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract
Median Technologies reports half-year liquidity contract details with TP ICAP. 60,808 shares and €58,893.66 cash as of June 30, 2025. 469 buy and 395 sell transactions in the first half of 2025 -
-
-
PRESS RELEASE
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Median Technologies discloses total voting rights and shares as of April 30, 2025, in compliance with regulations. The French company utilizes AI for cancer diagnosis and treatment -
PRESS RELEASE
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital de Median Technologies au 30 avril 2025, société spécialisée en logiciels dispositifs médicaux et imagerie médicale -
-
-
PRESS RELEASE
Etat membre d'origine / Choix de l’autorité compétente pour le contrôle de l’information réglementée
Median Technologies confirms eligibility for the PEA-PME scheme, meeting criteria of <5,000 employees and annual turnover <1.5 billion euros. Shares remain in PEA-PME accounts with tax benefits
